AlzeCure Pharma Financial Flexibility Index
AlzeCure Pharma financial flexibility index. AlzeCure Pharma (ALZCUR) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of Skr-7.62 Million (operating CF Skr-7.62 Million minus capex Skr0.00) represents 0% of total liabilities (Skr15.93 Million). See how much free cash does AlzeCure Pharma generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AlzeCure Pharma (2017–2024)
Financial flexibility index of AlzeCure Pharma from 2017 to 2024. Historical Financial Flexibility Index trend for AlzeCure Pharma across 8 annual periods. Explore ALZCUR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
AlzeCure Pharma Financial Flexibility Index by Year (2017–2024)
AlzeCure Pharma financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for AlzeCure Pharma. For the full cash flow conversion analysis, see cash efficiency ratio of AlzeCure Pharma.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.24x | Skr-35.00 Million | Skr-35.12 Million | Skr8.25 Million | ▼ -1241.7% |
| 2023 | 0.37x | Skr3.06 Million | Skr3.06 Million | Skr8.23 Million | ▲ +103.9% |
| 2022 | -9.65x | Skr-99.91 Million | Skr-99.91 Million | Skr10.35 Million | ▼ -73.2% |
| 2021 | -5.57x | Skr-70.58 Million | Skr-70.64 Million | Skr12.67 Million | ▲ +42.8% |
| 2020 | -9.73x | Skr-68.84 Million | Skr-69.51 Million | Skr7.07 Million | ▲ +5.3% |
| 2019 | -10.28x | Skr-48.82 Million | Skr-50.28 Million | Skr4.75 Million | ▼ -32.4% |
| 2018 | -7.76x | Skr-35.81 Million | Skr-36.27 Million | Skr4.61 Million | ▼ -294.8% |
| 2017 | -1.97x | Skr-8.15 Million | Skr-8.42 Million | Skr4.15 Million | — |